Analysis of T cells recruited during delayed-type hypersensitivity to purified protein derivative (PPD) versus challenge with tuberculosis infection

T F Pais, R A Silva, B Smedegaard, R Appelberg, P Andersen, T F Pais, R A Silva, B Smedegaard, R Appelberg, P Andersen

Abstract

The delayed-type hypersensitivity (DTH) to purified protein derivative (PPD) test has been used to infer about protective immunity to Mycobacterium tuberculosis and to diagnose tuberculosis. We showed that in memory tuberculosis-immune mice both DTH to PPD and resistance to M. tuberculosis could be effectively elicited in the footpad and both reactions led to the accumulation of reactive T cells in the regional lymph nodes with a CD4+ phenotype and characterized by the secretion of high levels of interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) and no IL-4. By adoptive transfer into nude mice of highly purified CD4+ T cells harvested during the recall of protective immunity it was confirmed that this population mediated both manifestations. However, the specificity of the T cells recruited during these processes were found to differ markedly; T cells involved in protection to a challenge with live tuberculosis bacilli recognized predominantly low-mass culture filtrate antigens below 15 000 MW, while cells recruited during DTH to PPD were directed to molecular mass fractions between 15 000 and 31 000. Using single purified antigens we showed that the latter cells recognized the secreted mycobacterial protein Ag85B and the heat-shock proteins, DnaK and GroEL. Protective T cells, in contrast, were characterized by a very high frequency of T cells directed to the ESAT-6 peptide 1-20.

References

    1. J Immunol. 1995 Apr 1;154(7):3359-72
    1. Infect Immun. 1988 Dec;56(12):3310-2
    1. J Infect Dis. 1971 Apr;123(4):439-45
    1. Infect Immun. 1991 Jun;59(6):1905-10
    1. Microbiol Rev. 1992 Dec;56(4):648-61
    1. Lancet. 1994 Nov 5;344(8932):1245-9
    1. Immunology. 1995 Jul;85(3):502-8
    1. Nature. 1982 May 20;297(5863):233-4
    1. Eur J Immunol. 1995 Oct;25(10):2877-81
    1. Am Rev Tuberc. 1955 May;71(5):752-4
    1. Infect Immun. 1991 Apr;59(4):1558-63
    1. Infect Immun. 1994 Jun;62(6):2536-44
    1. J Immunol. 1992 Jan 1;148(1):189-96
    1. Am Rev Tuberc. 1952 Apr;65(4):402-28
    1. Infect Immun. 1993 Mar;61(3):844-51
    1. Scand J Immunol. 1997 Feb;45(2):115-31
    1. J Immunol Methods. 1993 May 5;161(1):29-39
    1. J Immunol. 1996 Oct 15;157(8):3527-33
    1. Am Rev Respir Dis. 1975 Feb;111(2):109-18
    1. Immunol Today. 1991 Jun;12(6):189-92
    1. J Immunol. 1988 May 15;140(10):3589-93
    1. Br Med J. 1967 Mar 11;1(5540):587-92
    1. J Immunol Methods. 1993 Jun 18;162(2):211-23
    1. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1530-4
    1. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12013-7
    1. Nat Med. 1996 Aug;2(8):888-92
    1. Am Rev Tuberc. 1958 Oct;78(4):583-603

Source: PubMed

3
订阅